|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Epizyme Inc. (EPZM)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-10-05 Purchase |
2018-10-05 6:36 pm |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
416,667 | $9 | $3,750,003 | 6,471,018 (Indirect Direct) |
View |
| 2018-02-05 Sale |
2018-02-06 4:26 pm |
Epizyme Inc. | EPZM | Ros Matthew COO |
72,264 | $16.63 | $1,201,695 | 74,867 (Direct) |
View |
| 2017-10-24 Sale |
2017-10-25 12:29 pm |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $16.44 | $246,591 | 23,123 (Indirect Direct) |
View |
| 2017-09-25 Sale |
2017-09-26 4:46 pm |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $16.81 | $252,076 | 23,123 (Indirect Direct) |
View |
| 2017-09-18 Purchase |
2017-09-18 4:27 pm |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
200,000 | $15.25 | $3,050,000 | 6,054,351 (Indirect Direct) |
View |
| 2017-08-24 Sale |
2017-08-28 1:39 pm |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $15.68 | $235,266 | 25,950 (Indirect Direct) |
View |
| 2017-07-24 Sale |
2017-07-26 5:19 pm |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $13.44 | $201,571 | 36,175 (Indirect Direct) |
View |
| 2017-06-30 Sale |
2017-07-05 3:47 pm |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
3,024 | $15.5 | $46,872 | 40,529 (Direct) |
View |
| 2017-06-26 Sale |
2017-06-27 3:13 pm |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $14.87 | $223,115 | 46,400 (Indirect Direct) |
View |
| 2017-06-06 Sale |
2017-06-07 1:48 pm |
Epizyme Inc. | EPZM | Copeland Robert A President of Research and CSO |
2,500 | $13.45 | $33,625 | 36,050 (Direct) |
View |
| 2017-05-25 Sale |
2017-05-26 11:20 am |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $16.11 | $241,664 | 56,625 (Indirect Direct) |
View |
| 2017-05-02 Sale |
2017-05-03 1:08 pm |
Epizyme Inc. | EPZM | Copeland Robert A President of Research and CSO |
5,000 | $17.44 | $87,212 | 38,550 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-07-23 Option Award |
2018-07-24 12:46 pm |
N/A 2028-07-22 |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
170,000 | $13.35 | 170,000 (Direct) |
View |
| 2018-07-02 Option Award |
2018-07-02 5:42 pm |
N/A N/A |
Epizyme Inc. | EPZM | SEIDENBERG BETH C Director |
3,247 | $13.55 | 4,115,555 (Direct) |
View |
| 2018-07-02 Option Award |
2018-07-02 5:37 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
6,088 | $13.55 | 6,054,351 (Direct) |
View |
| 2018-07-02 Option Award |
2018-07-02 5:34 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
2,878 | $13.55 | 2,878 (Direct) |
View |
| 2018-05-18 Option Award |
2018-05-31 4:29 pm |
N/A 2028-05-17 |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
12,500 | $17 | 12,500 (Direct) |
View |
| 2018-05-18 Option Award |
2018-05-31 4:28 pm |
N/A 2028-05-17 |
Epizyme Inc. | EPZM | Allen Andrew R Director |
12,500 | $17 | 12,500 (Direct) |
View |
| 2018-05-18 Option Award |
2018-05-31 4:27 pm |
N/A 2028-05-17 |
Epizyme Inc. | EPZM | POPS RICHARD F Director |
12,500 | $17 | 12,500 (Direct) |
View |
| 2018-05-18 Option Award |
2018-05-31 4:26 pm |
N/A 2028-05-17 |
Epizyme Inc. | EPZM | SEIDENBERG BETH C Director |
12,500 | $17 | 12,500 (Direct) |
View |
| 2018-05-18 Option Award |
2018-05-31 4:25 pm |
N/A 2028-05-17 |
Epizyme Inc. | EPZM | BATE KENNETH Director |
12,500 | $17 | 12,500 (Direct) |
View |
| 2018-05-18 Option Award |
2018-05-31 4:24 pm |
N/A 2028-05-17 |
Epizyme Inc. | EPZM | GOLDFISCHER CARL Director |
12,500 | $17 | 12,500 (Direct) |
View |
| 2018-05-18 Option Award |
2018-05-31 4:23 pm |
N/A 2028-05-17 |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
12,500 | $17 | 12,500 (Direct) |
View |
| 2018-03-08 Option Award |
2018-03-12 4:53 pm |
N/A 2028-03-07 |
Epizyme Inc. | EPZM | Giordano Michael F Director |
25,000 | $17.6 | 25,000 (Direct) |
View |
| 2018-02-09 Option Award |
2018-02-13 5:08 pm |
N/A 2028-02-08 |
Epizyme Inc. | EPZM | Ros Matthew COO |
106,344 | $16 | 106,344 (Direct) |
View |
| 2018-02-09 Option Award |
2018-02-13 5:05 pm |
N/A 2028-02-08 |
Epizyme Inc. | EPZM | Graf Susan E Chief Business Officer |
106,344 | $16 | 106,344 (Direct) |
View |
| 2018-02-09 Option Award |
2018-02-13 5:04 pm |
N/A 2028-02-08 |
Epizyme Inc. | EPZM | Bazemore Robert B CEO |
265,860 | $16 | 265,860 (Direct) |
View |
| 2018-02-09 Option Award |
2018-02-13 5:02 pm |
N/A 2028-02-08 |
Epizyme Inc. | EPZM | Fleming Suzanne VP |
29,002 | $16 | 29,002 (Direct) |
View |
| 2018-02-05 Exercise |
2018-02-06 4:26 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ros Matthew COO |
72,264 | $9.58 | 74,867 (Direct) |
View |
| 2018-02-05 Exercise |
2018-02-06 4:26 pm |
N/A 2027-05-15 |
Epizyme Inc. | EPZM | Ros Matthew COO |
72,264 | $9.58 | 74,867 (Direct) |
View |
| 2017-10-24 Exercise |
2017-10-25 12:29 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 23,123 (Direct) |
View |
| 2017-10-24 Exercise |
2017-10-25 12:29 pm |
N/A 2026-02-07 |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 23,123 (Direct) |
View |
| 2017-09-25 Exercise |
2017-09-26 4:46 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 23,123 (Direct) |
View |
| 2017-09-25 Exercise |
2017-09-26 4:46 pm |
N/A 2026-02-07 |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 23,123 (Direct) |
View |
| 2017-09-20 Option Award |
2017-09-21 3:33 pm |
N/A 2027-09-19 |
Epizyme Inc. | EPZM | Fleming Suzanne VP |
90,180 | $18.7 | 90,180 (Direct) |
View |
| 2017-08-24 Exercise |
2017-08-28 1:39 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 25,950 (Direct) |
View |
| 2017-08-24 Exercise |
2017-08-28 1:39 pm |
N/A 2026-02-07 |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 25,950 (Direct) |
View |
| 2017-08-09 Exercise |
2017-08-10 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 45,446 (Direct) |
View |
| 2017-08-09 Exercise |
2017-08-10 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
778 | $0 | 45,446 (Direct) |
View |
| 2017-08-09 Exercise |
2017-08-10 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 45,446 (Direct) |
View |
| 2017-08-09 Exercise |
2017-08-10 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
778 | $0 | 45,446 (Direct) |
View |
| 2017-07-24 Exercise |
2017-07-26 5:19 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 36,175 (Direct) |
View |
| 2017-07-24 Exercise |
2017-07-26 5:19 pm |
N/A 2026-02-07 |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 36,175 (Direct) |
View |
| 2017-07-10 Exercise |
2017-07-12 1:57 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 42,986 (Direct) |
View |
| 2017-07-10 Exercise |
2017-07-12 1:57 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
777 | $0 | 42,986 (Direct) |
View |
| 2017-07-10 Exercise |
2017-07-12 1:57 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 42,986 (Direct) |
View |
| 2017-07-10 Exercise |
2017-07-12 1:57 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
777 | $0 | 42,986 (Direct) |
View |
| 2017-06-26 Exercise |
2017-06-27 3:13 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 46,400 (Direct) |
View |
| 2017-06-26 Exercise |
2017-06-27 3:13 pm |
N/A 2026-02-07 |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 46,400 (Direct) |
View |
| 2017-06-22 Option Award |
2017-06-26 4:00 pm |
N/A 2027-06-21 |
Epizyme Inc. | EPZM | BATE KENNETH Director |
12,500 | $13.65 | 12,500 (Direct) |
View |
| 2017-06-22 Option Award |
2017-06-26 3:37 pm |
N/A 2027-06-21 |
Epizyme Inc. | EPZM | MOTT DAVID M Director, 10% Owner |
12,500 | $13.65 | 12,500 (Direct) |
View |
| 2017-06-22 Option Award |
2017-06-26 1:57 pm |
N/A 2027-06-21 |
Epizyme Inc. | EPZM | Allen Andrew R Director |
12,500 | $13.65 | 12,500 (Direct) |
View |
| 2017-06-22 Option Award |
2017-06-26 1:56 pm |
N/A 2027-06-21 |
Epizyme Inc. | EPZM | POPS RICHARD F Director |
12,500 | $13.65 | 12,500 (Direct) |
View |
| 2017-06-22 Option Award |
2017-06-26 1:54 pm |
N/A 2027-06-21 |
Epizyme Inc. | EPZM | GOLDFISCHER CARL Director |
12,500 | $13.65 | 12,500 (Direct) |
View |
| 2017-06-22 Option Award |
2017-06-26 1:53 pm |
N/A 2027-06-21 |
Epizyme Inc. | EPZM | SEIDENBERG BETH C Director |
12,500 | $13.65 | 12,500 (Direct) |
View |
| 2017-06-09 Exercise |
2017-06-12 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 43,553 (Direct) |
View |
| 2017-06-09 Exercise |
2017-06-12 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
777 | $0 | 43,553 (Direct) |
View |
| 2017-06-09 Exercise |
2017-06-12 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 43,553 (Direct) |
View |
| 2017-06-09 Exercise |
2017-06-12 3:47 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
777 | $0 | 43,553 (Direct) |
View |
| 2017-06-06 Exercise |
2017-06-07 1:48 pm |
N/A N/A |
Epizyme Inc. | EPZM | Copeland Robert A President of Research and CSO |
2,500 | $3.54 | 36,050 (Direct) |
View |
| 2017-06-06 Exercise |
2017-06-07 1:48 pm |
N/A 2023-01-24 |
Epizyme Inc. | EPZM | Copeland Robert A President of Research and CSO |
2,500 | $3.54 | 36,050 (Direct) |
View |
| 2017-05-25 Exercise |
2017-05-26 11:20 am |
N/A N/A |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 56,625 (Direct) |
View |
| 2017-05-25 Exercise |
2017-05-26 11:20 am |
N/A 2026-02-07 |
Epizyme Inc. | EPZM | Ho Peter Tai-Ching Chief Development Officer |
15,000 | $8.98 | 56,625 (Direct) |
View |
| 2017-05-09 Exercise |
2017-05-11 2:27 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 41,094 (Direct) |
View |
| 2017-05-09 Exercise |
2017-05-11 2:27 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
778 | $0 | 41,094 (Direct) |
View |
| 2017-05-09 Exercise |
2017-05-11 2:27 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 41,094 (Direct) |
View |
| 2017-05-09 Exercise |
2017-05-11 2:27 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
778 | $0 | 41,094 (Direct) |
View |
| 2017-05-02 Exercise |
2017-05-03 1:08 pm |
N/A N/A |
Epizyme Inc. | EPZM | Copeland Robert A President of Research and CSO |
5,000 | $3.54 | 38,550 (Direct) |
View |
| 2017-05-02 Exercise |
2017-05-03 1:08 pm |
N/A 2023-01-24 |
Epizyme Inc. | EPZM | Copeland Robert A President of Research and CSO |
5,000 | $3.54 | 38,550 (Direct) |
View |
| 2017-04-10 Exercise |
2017-04-11 1:34 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 38,634 (Direct) |
View |
| 2017-04-10 Exercise |
2017-04-11 1:34 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
777 | $0 | 38,634 (Direct) |
View |
| 2017-04-10 Exercise |
2017-04-11 1:34 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
1,682 | $0 | 38,634 (Direct) |
View |
| 2017-04-10 Exercise |
2017-04-11 1:34 pm |
N/A N/A |
Epizyme Inc. | EPZM | Singer Andrew E. CFO |
777 | $0 | 38,634 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Tue, 23 Jul 2019 10:50:47 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |